Home

Chalupa Odhadováno součet a 485 Odchod Třída Sirotek

Bundesautobahn 485 - Wikipedia
Bundesautobahn 485 - Wikipedia

A-485 | SGC
A-485 | SGC

A-485 | p300/CBP Inhibitor | MedChemExpress
A-485 | p300/CBP Inhibitor | MedChemExpress

A-485 | SGC
A-485 | SGC

Discovery of a Potent and Selective Covalent p300/CBP Inhibitor | ACS  Medicinal Chemistry Letters
Discovery of a Potent and Selective Covalent p300/CBP Inhibitor | ACS Medicinal Chemistry Letters

A-485 potently inhibits p300/CBP in vitro (a) Chemical structures of... |  Download Scientific Diagram
A-485 potently inhibits p300/CBP in vitro (a) Chemical structures of... | Download Scientific Diagram

A-485 (CAS Number: 1889279-16-6) | Cayman Chemical
A-485 (CAS Number: 1889279-16-6) | Cayman Chemical

A-485 potently inhibits p300/CBP in cells (a) Analysis of high content... |  Download Scientific Diagram
A-485 potently inhibits p300/CBP in cells (a) Analysis of high content... | Download Scientific Diagram

A-485 potently inhibits p300/CBP in cells (a) Analysis of high content... |  Download Scientific Diagram
A-485 potently inhibits p300/CBP in cells (a) Analysis of high content... | Download Scientific Diagram

A-485 | p300/CBP Inhibitor | MedChemExpress
A-485 | p300/CBP Inhibitor | MedChemExpress

A novel histone acetyltransferase inhibitor A485 improves sensitivity of  non-small-cell lung carcinoma cells to TRAIL - ScienceDirect
A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL - ScienceDirect

A-485 | SGC
A-485 | SGC

A novel histone acetyltransferase inhibitor A485 improves sensitivity of  non-small-cell lung carcinoma cells to TRAIL - ScienceDirect
A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL - ScienceDirect

CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory  axis in proliferation | Epigenetics & Chromatin | Full Text
CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation | Epigenetics & Chromatin | Full Text

A-485 | SGC
A-485 | SGC

RCSB PDB - 5KJ2: The novel p300/CBP inhibitor A-485 uncovers a unique  mechanism of action to target AR in castrate resistant prostate cancer
RCSB PDB - 5KJ2: The novel p300/CBP inhibitor A-485 uncovers a unique mechanism of action to target AR in castrate resistant prostate cancer

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT  midline carcinoma | Oncogene
Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma | Oncogene

Promoter-specific changes in initiation, elongation, and homeostasis of  histone H3 acetylation during CBP/p300 inhibition | eLife
Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition | eLife

Selective inhibition of CBP/p300 HAT by A-485 results in suppression of  lipogenesis and hepatic gluconeogenesis | Cell Death & Disease
Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis | Cell Death & Disease

p300/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and  protects against osteoporotic bone loss - ScienceDirect
p300/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss - ScienceDirect

Discovery of a Potent and Selective Covalent p300/CBP Inhibitor | ACS  Medicinal Chemistry Letters
Discovery of a Potent and Selective Covalent p300/CBP Inhibitor | ACS Medicinal Chemistry Letters

Selective inhibition of CBP/p300 HAT by A-485 results in suppression of  lipogenesis and hepatic gluconeogenesis | Cell Death & Disease
Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis | Cell Death & Disease

A-485 | p300/CBP Inhibitor | Tocris Bioscience
A-485 | p300/CBP Inhibitor | Tocris Bioscience

Selective inhibition of CBP/p300 HAT by A-485 results in suppression of  lipogenesis and hepatic gluconeogenesis | Cell Death & Disease
Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis | Cell Death & Disease

Probe A-485 | Chemical Probes Portal
Probe A-485 | Chemical Probes Portal

A-485 | SGC
A-485 | SGC

A novel histone acetyltransferase inhibitor A485 improves sensitivity of  non-small-cell lung carcinoma cells to TRAIL - ScienceDirect
A novel histone acetyltransferase inhibitor A485 improves sensitivity of non-small-cell lung carcinoma cells to TRAIL - ScienceDirect